Cargando…

Cardiovascular Risk and Health Among People With Human Immunodeficiency Virus (HIV) Eligible for Primary Prevention: Insights From the REPRIEVE Trial

BACKGROUND: In addition to traditional cardiovascular (CV) risk factors, antiretroviral therapy, lifestyle, and human immunodeficiency virus (HIV)-related factors may contribute to future CV events in persons with HIV (PWH). METHODS: Among participants in the global REPRIEVE randomized trial, we cha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Douglas, Pamela S, Umbleja, Triin, Bloomfield, Gerald S, Fichtenbaum, Carl J, Zanni, Markella V, Overton, Edgar T, Fitch, Kathleen V, Kileel, Emma M, Aberg, Judith A, Currier, Judith, Sponseller, Craig A, Melbourne, Kathleen, Avihingsanon, Anchalee, Bustorff, Flavio, Estrada, Vicente, Ruxrungtham, Kiat, Saumoy, Maria, Navar, Ann Marie, Hoffmann, Udo, Ribaudo, Heather J, Grinspoon, Steven
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Major Articles and Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664454/ https://www.ncbi.nlm.nih.gov/pubmed/34134131 http://dx.doi.org/10.1093/cid/ciab552

Ejemplares similares

Assessment of Obesity and Cardiometabolic Status by Integrase Inhibitor Use in REPRIEVE: A Propensity-Weighted Analysis of a Multinational Primary Cardiovascular Prevention Cohort of People With Human Immunodeficiency Virus
por: Kileel, Emma M, et al.
Publicado: (2021)

The importance of methods for site performance evaluation in REPRIEVE, a longitudinal, global, multicenter trial
por: Fulda, Evelynne S., et al.
Publicado: (2023)

Assessment of Coronary Artery Disease With Computed Tomography Angiography and Inflammatory and Immune Activation Biomarkers Among Adults With HIV Eligible for Primary Cardiovascular Prevention
por: Hoffmann, Udo, et al.
Publicado: (2021)

Ideal cardiovascular health, biomarkers, and coronary artery disease in persons with HIV
por: Douglas, Pamela S., et al.
Publicado: (2023)

Diet in a global cohort of adults with HIV at low-to-moderate traditional cardiovascular disease risk
por: Fitch, Kathleen V., et al.
Publicado: (2022)

Identification of pre-infection markers and differential plasma protein expression following SARS-CoV-2 infection in people living with HIV
por: Kolossváry, Márton, et al.
Publicado: (2023)

Assessing statin effects on cardiovascular pathways in HIV using a novel proteomics approach: Analysis of data from INTREPID, a randomized controlled trial
por: Toribio, Mabel, et al.
Publicado: (2018)

Reprieve for Perchlorate
por: Renner, R
Publicado: (2002)

Biological and Clinical Implications of the Vascular Endothelial Growth Factor Coreceptor Neuropilin-1 in Human Immunodeficiency Virus
por: Schnittman, Samuel R, et al.
Publicado: (2023)

Sex Differences in Subclinical Atherosclerosis and Systemic Immune Activation/Inflammation Among People With Human Immunodeficiency Virus in the United States
por: Zanni, Markella V, et al.
Publicado: (2022)

Effect of host factors and COVID-19 infection on the humoral immune repertoire in treated HIV
por: Schnittman, Samuel R., et al.
Publicado: (2023)

Coronary Artery Plaque Composition and Severity Relate to the Inflammasome in People With Treated Human Immunodeficiency Virus
por: Schnittman, Samuel R, et al.
Publicado: (2023)

Rationale and clinical utility of the darunavir–cobicistat combination in the treatment of HIV/AIDS
por: Putcharoen, Opass, et al.
Publicado: (2015)

COVID-19 and HIV infection co-pandemics and their impact: a review of the literature
por: Gatechompol, Sivaporn, et al.
Publicado: (2021)

Efficacy and improvement of lipid profile after switching to rilpivirine in resource limited setting: real life clinical practice
por: Gatechompol, Sivaporn, et al.
Publicado: (2019)

No Reprieve: Extreme Heat at Night Contributes to Heat Wave Mortality
por: Seltenrich, Nate
Publicado: (2023)

Role of Rilpivirine and Etravirine in Efavirenz and Nevirapine-Based Regimens Failure in a Resource-Limited Country: A Cross- Sectional Study
por: Teeranaipong, Phairote, et al.
Publicado: (2016)

A Randomized Trial of Iloperidone for Prevention of Relapse in Schizophrenia: The REPRIEVE Study
por: Weiden, Peter J., et al.
Publicado: (2016)

Post-Myocardial Infarction Ventricular Septal Defect: No Reprieve From Doom?
por: Russo, Giulio, et al.
Publicado: (2022)

Proprotein Convertase Subtilisin/Kexin 9 Levels in Relation to Systemic Immune Activation and Subclinical Coronary Plaque in HIV
por: Zanni, Markella V, et al.
Publicado: (2017)

Effects of Integrase Inhibitor–Based ART on the NLRP3 Inflammasome Among ART-Naïve People With HIV
por: Toribio, Mabel, et al.
Publicado: (2020)

CD4/CD8 ratio normalization rates and low ratio as prognostic marker for non-AIDS defining events among long-term virologically suppressed people living with HIV
por: Han, Win Min, et al.
Publicado: (2018)

Pharmaceutical Equivalence of Distributed Generic Antiretroviral (ARV) in Asian Settings: The Cross-Sectional Surveillance Study – PEDA Study
por: Sapsirisavat, Vorapot, et al.
Publicado: (2016)

Aspartame Intake Relates to Coronary Plaque Burden and Inflammatory Indices in Human Immunodeficiency Virus
por: Hall, Leangelo N., et al.
Publicado: (2017)

A Reprieve from US wildlife mortality on roads during the COVID-19 pandemic
por: Shilling, Fraser, et al.
Publicado: (2021)

Eliciting perspectives of the key study population: An effective strategy to inform advertisement, content and usability of an online survey for a national investigation
por: Kileel, Emma M., et al.
Publicado: (2020)

Adherence and Risk Behaviour in Patients with HIV Infection Receiving Antiretroviral Therapy in Bangkok
por: Clarke, Amanda, et al.
Publicado: (2012)

Treatment outcomes and factors associated with mortality among individuals with both TB and HIV in the antiretroviral era in Thailand
por: Gatechompol, Sivaporn, et al.
Publicado: (2019)

Statins for primary cardiovascular disease prevention among people with HIV: emergent directions
por: Fitch, Kathleen V., et al.
Publicado: (2022)

Everybody's Page: How to Live to One Hundred.—A Word on Exercise.—A Welcome Reprieve, etc.
Publicado: (1888)

Comparable carotid intima-media thickness among long-term virologically suppressed individuals with HIV and those without HIV in Thailand
por: Putcharoen, Opass, et al.
Publicado: (2019)

Sextech Use as a Potential Mental Health Reprieve: The Role of Anxiety, Depression, and Loneliness in Seeking Sex Online
por: Marcotte, Alexandra S., et al.
Publicado: (2021)

Assessment of HBV flare in a randomized clinical trial in HIV/HBV coinfected subjects initiating HBV-active antiretroviral therapy in Thailand
por: Avihingsanon, Anchalee, et al.
Publicado: (2012)

Characteristics of suboptimal immune response after initiating antiretroviral therapy among people living with HIV with a pre-treatment CD4 T cell count <200 cells/mm(3) in Thailand()
por: Han, Win Min, et al.
Publicado: (2020)

Anogenital human papillomavirus virus DNA and sustained response to the quadrivalent HPV vaccine in women living with HIV-1
por: Cespedes, Michelle S., et al.
Publicado: (2018)

The Association of Distinct Social Determinants of Health with Added Sweetener Knowledge and Consumption in a U.S. Sample of People Living with HIV
por: Kileel, Emma M., et al.
Publicado: (2021)

Comparison of visceral fat measurement by dual-energy X-ray absorptiometry to computed tomography in HIV and non-HIV
por: Fourman, Lindsay T., et al.
Publicado: (2019)

Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2014, Thailand
por: Manosuthi, Weerawat, et al.
Publicado: (2015)

Quantitative HBsAg and HBeAg Predict Hepatitis B Seroconversion after Initiation of HAART in HIV-HBV Coinfected Individuals
por: Matthews, Gail V., et al.
Publicado: (2013)

The challenges of ending AIDS in Asia: outcomes of the Thai National AIDS Universal Coverage Programme, 2000–2014
por: Chaivooth, Suchada, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_grb11v2oko8m012fhrvth76udn